GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) » Definitions » Change In Inventory

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Change In Inventory : HK$0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sichuan Kelun-Biotech Biopharmaceutical Co Change In Inventory?

Sichuan Kelun-Biotech Biopharmaceutical Co's change in inventory for the quarter that ended in Dec. 2024 was HK$0 Mil. It means Sichuan Kelun-Biotech Biopharmaceutical Co's inventory stayed the same from Jun. 2024 to Dec. 2024 .

Sichuan Kelun-Biotech Biopharmaceutical Co's change in inventory for the fiscal year that ended in Dec. 2024 was HK$-51 Mil. It means Sichuan Kelun-Biotech Biopharmaceutical Co's inventory increased by HK$51 Mil from Dec. 2023 to Dec. 2024 .

Sichuan Kelun-Biotech Biopharmaceutical Co's Total Inventories for the quarter that ended in Dec. 2024 was HK$118 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sichuan Kelun-Biotech Biopharmaceutical Co's Days Inventory for the quarter that ended in Dec. 2024 was 44.41.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sichuan Kelun-Biotech Biopharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2024 was 4.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sichuan Kelun-Biotech Biopharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.16.

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Inventory Historical Data

The historical data trend for Sichuan Kelun-Biotech Biopharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Inventory Chart

Sichuan Kelun-Biotech Biopharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Change In Inventory
-45.65 29.11 -11.37 -50.69

Sichuan Kelun-Biotech Biopharmaceutical Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Inventory Get a 7-Day Free Trial - - - - -

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Kelun-Biotech Biopharmaceutical Co  (HKSE:06990) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sichuan Kelun-Biotech Biopharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=91.779/377.195*365 / 2
=44.41

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sichuan Kelun-Biotech Biopharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=377.195 / 91.779
=4.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sichuan Kelun-Biotech Biopharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=91.779 / 587.491
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun-Biotech Biopharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) » Definitions » Change In Inventory
Comparable Companies
HKSE:01177 HKSE:09926 HKSE:01801 HKSE:02269 HKSE:01877 HKSE:09995 HKSE:01530 HKSE:01548 HKSE:02696 HKSE:09969 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 666 Xinhua Avenue, Chengdu Cross-Strait Science and Technology Industry Development Park, Wenjiang, Sichuan, Chengdu, CHN
Website
http://www.kelun-biotech.com
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
Executives
Liu Gexin 2201 Interest of corporation controlled by you
Si Chuan Ke Lun Yao Ye Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Cheng Du Ke Lun Jing Chuan Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Wellington Management Group Llp 2102 Investment manager
Merck & Co., Inc. 2201 Interest of corporation controlled by you
Merck Sharp & Dohme Llc 2101 Beneficial owner
Ke Lun Guo Ji Fa Zhan You Xian Gong Si 2101 Beneficial owner
Li Jun 2201 Interest of corporation controlled by you
Zhou Quan 2201 Interest of corporation controlled by you
Idg Breyer Capital Fund Gp Associates L.p. 2201 Interest of corporation controlled by you
Idg Breyer Capital Fund Gp Associates Ltd. 2201 Interest of corporation controlled by you
Idg Breyer Capital Fund L.p. 2201 Interest of corporation controlled by you
Victory Rhythm Limited 2201 Interest of corporation controlled by you
Wealthy Linkage Limited 2101 Beneficial owner
Ho Chi Sing 2201 Interest of corporation controlled by you

Sichuan Kelun-Biotech Biopharmaceutical Co Headlines

No Headlines